Malta vs Portugal: Cause of death, by non-communicable diseases, ages 5-14, male
Malta
74.7%
in 2021
Portugal
73.3%
in 2021
Malta rank
6th
Portugal rank
7th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Malta
- Portugal
How they compare
Malta currently reports 74.7% against 73.3% in Portugal, a difference of 1.4%.
The two have swapped places 5 times across 6 shared years of data; in 2000 it was Portugal ahead.
Malta ranks 6th and Portugal ranks 7th of 185 countries.
Across the 3 decades both report, Malta averaged higher in 1 and Portugal in 2.
Head to head by decade
| Decade | Malta | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.9% | 49.3% | 12.4% | Portugal |
| 2010s | 85.6% | 72.5% | 13.1% | Malta |
| 2020s | 66.7% | 74.0% | 7.2% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Malta or Portugal?
- Malta, at 74.7% against 73.3% in Portugal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Malta and Portugal?
- 1.4%, with Malta ahead.
- How many years of comparable data are there for Malta and Portugal?
- 6 years are reported by both, from 2000 to 2021.
- How do Malta and Portugal rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Malta ranks 6th and Portugal ranks 7th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.